Skip to main content
EJNMMI Reports
Fig. 4 | European Journal of Hybrid Imaging

Fig. 4

From: Skeletal standardized uptake values obtained by quantitative SPECT/CT as an osteoblastic biomarker for the discrimination of active bone metastasis in prostate cancer

Fig. 4

Changes in analysis parameters with skeletal disease extent. There was significant change in alkaline phosphatase (ALP, a), prostate specific antigen (PSA, b), maximum and average of standardized uptake values (SUVmax, c; SUVave, d) with change in extent of disease (EOD) grade. ALP and PSA demonstrated an increasing trend with increase in EOD grade, while SUVmax showed a relatively lower maximum value in grade 4 disease. Please note that the scale of the graph for PSA (b) is logarithmic

Back to article page